|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.08 USD | +1.07% |
|
+3.81% | +1.10% |
| 09:07pm | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech -- Update | DJ |
| 08:26pm | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech | DJ |
Chart calendar Pfizer Inc.
Upcoming events on Pfizer Inc.
| 24/07/2026 | Ex-dividend date - 0.43 USD | 12:00 |
| 04/08/2026 | Earnings presentation | 22:00 |
| 04/08/2026 | Earnings release - Q2 2026 |
Past events on Pfizer Inc.
| 06/06/2026 | Information meeting | 23:00 |
| 05/05/2026 | Earnings presentation | 22:00 |
| 05/05/2026 | Earnings release - Q1 2026 | |
| 23/04/2026 | Annual General Meeting | 21:00 |
| 23/04/2026 | Présentation aux Actionnaires / Analystes | 21:00 |
| 03/02/2026 | Earnings presentation | 23:00 |
| 03/02/2026 | Earnings release - Q4 2025 | 23:00 |
| 10/11/2025 | Information meeting | 21:30 |
| 04/11/2025 | Earnings release - Q3 2025 | |
| 04/11/2025 | Earnings presentation | 23:00 |
| 05/08/2025 | Earnings presentation | 22:00 |
Past dividends on Pfizer Inc.
| 08/05/2026 | Ex-dividend date - 0.43 USD | 12:00 |
| 23/01/2026 | Ex-dividend date - 0.43 USD | 13:00 |
| 07/11/2025 | Ex-dividend date - 0.43 USD | 13:00 |
| 25/07/2025 | Ex-dividend date - 0.43 USD | 12:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 58 496 59 105 -1.03% | 63 627 63 071 0.88% | 62 579 61 941 1.03% | 61 737 | 59 198 | 54 939 |
|
EBITDA Million USD | Released Forecast Spread | 15 590 11 249 38.59% | 28 801 25 482 13.03% | 28 563 25 004 14.23% | 24 429 | 23 678 | 20 531 |
|
EBIT Million USD | Released Forecast Spread | 9 300 8 509 9.3% | 21 788 20 589 5.82% | 21 971 21 223 3.53% | 21 614 | 20 391 | 17 643 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 058 2 301 -54.02% | 8 023 11 544 -30.5% | 7 520 12 438 -39.54% | 11 253 | 12 397 | 11 666 |
|
Net income Million USD | Released Forecast Spread | 2 119 3 040 -30.29% | 8 031 9 732 -17.47% | 7 771 12 287 -36.75% | 10 627 | 10 268 | 9 418 |
|
EPS USD | Released Forecast Spread | 0,37 0,72 -48.44% | 1,41 1,70 -17.17% | 1,36 2,14 -36.34% | 1,97 | 1,90 | 1,61 |
| Announcement Date | 30/01/24 | 04/02/25 | 03/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17 702 14 865 19.08% | 17 763 17 264 2.89% | 13 715 14 051 -2.39% | 14 653 13 531 8.29% | 16 654 16 502 0.92% | 17 557 16 828 4.33% | 14 451 13 802 4.7% | 14 406 | 16 070 | 16 884 | 13 579 | 13 882 | 15 737 | 16 274 |
|
EBITDA Million USD | Released Forecast Spread | 7 478 4 647 60.92% | 6 391 4 136 54.54% | 7 548 6 180 22.14% | 6 940 5 487 26.49% | 7 303 6 229 17.23% | 6 770 6 073 11.47% | 7 172 6 329 13.32% | 6 032 | 6 994 | 6 070 | 5 334 | |||
|
EBIT Million USD | Released Forecast Spread | 7 035 3 978 76.86% | 4 672 3 357 39.18% | 5 930 4 982 19.02% | 5 315 4 410 20.51% | 5 641 4 704 19.93% | 5 083 4 275 18.89% | 5 559 5 329 4.31% | 5 033 | 6 016 | 5 110 | 4 809 | 5 060 | 6 154 | 4 685 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 715 2 616 80.24% | -10,0 2 104 -100.48% | 2 785 3 880 -28.22% | 3 044 2 468 23.34% | 3 334 3 240 2.9% | -1 642 3 002 -154.71% | 3 170 3 966 -20.07% | 3 092 | 4 645 | 2 544 | ||||
|
Net income Million USD | Released Forecast Spread | 4 465 1 725 158.79% | 410 1 002 -59.1% | 2 967 2 913 1.86% | 2 910 2 063 41.07% | 3 541 2 334 51.72% | -1 648 2 208 -174.64% | 2 687 2 981 -9.86% | 2 565 | 3 371 | 2 245 | 2 777 | 3 168 | 4 110 | 2 878 |
|
EPS USD | Released Forecast Spread | 0,78 0,30 160.81% | 0,07 0,20 -65.43% | 0,52 0,51 2.91% | 0,51 0,36 41.65% | 0,62 0,44 42.49% | -0,29 0,39 -173.87% | 0,47 0,52 -9.48% | 0,45 | 0,59 | 0,39 | 0,49 | 0,56 | 0,72 | 0,50 |
| Announcement Date | 29/10/24 | 04/02/25 | 29/04/25 | 05/08/25 | 04/11/25 | 03/02/26 | 05/05/26 | - | - | - | - | - | - | - |
| 17/07/2026 |  | Ex-dividend date - 18 INR | 12:00 |
| 17/07/2026 | | Earnings release - Q2 2026 | |
| 17/07/2026 | | Earnings presentation | 19:00 |
| 17/07/2026 | | Extraordinary General Meeting | 15:30 |
| 17/07/2026 | | Extraordinary General Meeting | 14:00 |
| 17/07/2026 | | Ex-dividend date - 75 INR | 12:00 |
| 17/07/2026 | | Ex-dividend date - 0.15182 CNY | 12:00 |
| 17/07/2026 | | Ex-dividend date - 0.064 CNY | 12:00 |
| 17/07/2026 | | Ex-dividend date - 0.84838 TWD | 12:00 |
| 17/07/2026 | | Significant Split/Dividend | 12:00 |
Past sector events for Pfizer Inc.
| Today | | Extraordinary General Meeting | 14:00 |
| Today | | Extraordinary General Meeting | 14:30 |
| 15/07/2026 | | Earnings release - Q2 2026 | 18:45 |
| 15/07/2026 | | Earnings presentation | 20:30 |
| 15/07/2026 | | Ex-dividend date - 1.73 USD | 12:00 |
| 15/07/2026 | | Information meeting | 20:00 |
| 15/07/2026 | | Earnings release - Q2 2026 | |
| 15/07/2026 | | Earnings presentation | 20:00 |
| 15/07/2026 | | Board of Directors Meeting | |
| 15/07/2026 | | Extraordinary General Meeting | 14:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
- Calendar Pfizer Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition